In multiple myeloma (MM), characterized by dysregulation of multiple factors due in large part to gene rearrangements and translocations of MYC [47], BRD4 was found to be enriched at IgH (immune heavy chain) enhancers rearranged at the MYC locus. Here, MYC is linked to plasma cell myeloma.